Molecules/LECANEMAB

LECANEMAB

Molecular Identity

AntibodyApprovedFirst approved 2023

Mechanism of action: Amyloid-beta A4 protein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BAN 2401BAN-2401BAN2401LECANEMABLECANEMAB IRMBLECANEMAB-IRMBLEQEMBI

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to LECANEMAB

Loading drug network...